Selective effects of Lactobacillus casei Shirota on T cell activation, natural killer cell activity and cytokine production.
Modulation of host immunity is an important potential mechanism by which probiotics confer health benefits. This study was designed to investigate the effects of a probiotic strain, Lactobacillus casei Shirota (LcS), on immune function using human peripheral blood mononuclear cells (PBMC) in vitro. In addition, the role of monocytes in LcS-induced immunity was also explored. LcS promoted natural killer (NK) cell activity and preferentially induced expression of CD69 and CD25 on CD8(+) and CD56(+) subsets in the absence of any other stimulus. LcS also induced production of interleukin (IL)-1beta, IL-6, tumour necrosis factor (TNF)-alpha, IL-12 and IL-10 in the absence of lipopolysaccharide (LPS). In the presence of LPS, LcS enhanced IL-1beta production but inhibited LPS-induced IL-10 and IL-6 production, and had no further effect on TNF-alpha and IL-12 production. Monocyte depletion reduced significantly the impact of LcS on lymphocyte activation, cytokine production and natural killer (NK) cell activity. In conclusion, LcS activated cytotoxic lymphocytes preferentially in both the innate and specific immune systems, which suggests that LcS could potentiate the destruction of infected cells in the body. LcS also induced both proinflammatory and anti-inflammatory cytokine production in the absence of LPS, but in some cases inhibited LPS-induced cytokine production. Monocytes play an important role in LcS-induced immunological responses.
Dong
H
H
Department of Food and Nutritional Sciences, University of Reading, Reading, UK.
Rowland
I
I
Tuohy
K M
KM
Thomas
L V
LV
Yaqoob
P
P
D000328:Adult; D015703:Antigens, CD / Q000378:metabolism; D000945:Antigens, Differentiation, T-Lymphocyte / Q000378:metabolism; D001769:Blood / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D018414:CD8-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D002469:Cell Separation; D002478:Cells, Cultured; D003208:Concanavalin A / Q000494:pharmacology; D016207:Cytokines / Q000378:metabolism*; D003602:Cytotoxicity, Immunologic / Q000276:immunology; D006801:Humans; D053645:Interleukin-2 Receptor alpha Subunit / Q000378:metabolism; D007378:Interleukins / Q000378:metabolism; D007694:Killer Cells, Natural / Q000276:immunology*; D007780:Lacticaseibacillus casei / Q000276:immunology*; D037181:Lectins, C-Type / Q000378:metabolism; D007963:Leukocytes, Mononuclear / Q000166:cytology / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D008070:Lipopolysaccharides / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects / Q000276:immunology*; D009000:Monocytes / Q000166:cytology / Q000276:immunology / Q000378:metabolism; D019936:Probiotics; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D000099192:CD69 Antigens
D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D003208:Concanavalin A; D016207:Cytokines; D053645:Interleukin-2 Receptor alpha Subunit; D007378:Interleukins; D037181:Lectins, C-Type; D008070:Lipopolysaccharides; D014409:Tumor Necrosis Factor-alpha; D000099192:CD69 Antigens; C508017:IL2RA protein, human
Eur J Clin Nutr. 2000 Mar;54(3):263-7
10713750
Gut. 2004 Nov;53(11):1602-9
15479680
Clin Vaccine Immunol. 2007 May;14(5):485-92
17360855
J Dairy Sci. 2005 Aug;88(8):2718-29
16027185
FEMS Immunol Med Microbiol. 2004 Oct 1;42(2):173-80
15364101
Eur J Clin Nutr. 2008 May;62(5):584-93
17440520
Clin Exp Allergy. 2008 Aug;38(8):1282-9
18510694
Clin Exp Allergy. 2005 Nov;35(11):1481-9
16297146
J Clin Immunol. 2001 Jul;21(4):264-71
11506196
Immunobiology. 2007;212(6):521-33
17544836
World J Gastroenterol. 2006 Oct 7;12(37):5978-86
17009396
FEMS Immunol Med Microbiol. 2003 Sep 22;38(2):165-72
13129651
Nutrition. 2007 Mar;23(3):254-60
17352961
Am J Reprod Immunol. 1995 Mar;33(3):221-7
7546238
Can J Gastroenterol. 2003 Nov;17(11):655-9
14631461
Mem Inst Oswaldo Cruz. 2002 Dec;97(8):1097-9
12563472
Nat Rev Immunol. 2001 Nov;1(2):135-45
11905821
J Immunol. 2000 Jul 1;165(1):139-47
10861046
Infect Immun. 2000 Feb;68(2):752-9
10639443
Clin Exp Immunol. 1999 May;116(2):276-82
10337019
J Gastroenterol. 2009;44(1):26-46
19159071
J Int Med Res. 2007 Mar-Apr;35(2):201-12
17542407
Clin Exp Immunol. 2007 Dec;150(3):531-8
17956582
JPEN J Parenter Enteral Nutr. 2004 Sep-Oct;28(5):348-54
15449576
J Nutr. 2007 Mar;137(3 Suppl 2):791S-3S
17311976
Cytotherapy. 2007;9(2):123-32
17453964
Clin Vaccine Immunol. 2006 Mar;13(3):365-75
16522779
Int Microbiol. 2006 Mar;9(1):47-52
16636989
J Am Coll Nutr. 2001 Apr;20(2 Suppl):149-56
11349938
Immunology. 2004 May;112(1):143-52
15096193
Biosci Biotechnol Biochem. 2000 Dec;64(12):2706-8
11210142
Clin Nutr. 2005 Aug;24(4):481-91
16054520
Immunol Invest. 2007;36(4):413-21
17691023
Br J Nutr. 2007 Nov;98(5):969-77
17617944
J Nutr. 2007 Mar;137(3 Suppl 2):781S-90S
17311975
Clin Vaccine Immunol. 2006 Sep;13(9):997-1003
16960110
Cytokine. 1999 Aug;11(8):600-5
10433807
Cytometry. 1999 Jun 15;38(3):95-101
10397327
Immunobiology. 2003;207(2):85-93
12675266
Ann Nutr Metab. 2006;50(3):282-9
16508257
Eur Urol. 1995;27(2):104-9
7744150
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2880-5
15710900
Int J Cancer. 2005 Sep 20;116(5):762-7
15828052
Clin Exp Immunol. 2006 Oct;146(1):109-15
16968405